Clinical Trial

Validation of RCC Predicting Model With Emulated-target Trial

Study acronym: RCCETT
Recruiting
View on ClinicalTrials.gov →
Summary
This single-center study utilizes real-world data (2012-2024) from 4700 renal cell carcinoma (RCC) patients at Peking University Third Hospital to: (1) Develop and validate a prognostic prediction model specifically for RCC patients, including those with venous tumor thrombus (VTT); (2) Compare the performance of this new model against existing RCC prediction models in both the overall RCC cohort and the VTT subgroup; (3) Employ an emulated target trial (ETT) methodology to evaluate whether risk-stratified treatment based on the prediction model (grouping patients as high/medium/low risk) improves survival outcomes .
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-08-11.
Status change: Not Yet Recruiting → Recruiting 2026-04-08
Trial Details
NCT Number NCT07117227
Lead Sponsor Peking University Third Hospital
Conditions Renal Cell Carcinoma (Kidney Cancer), Renal Cell Carcinoma (RCC), Tumor Thrombus, Prognosis, Prognostic Cancer Model, Real World Study, Observational Study
Enrollment 4,700 participants
Start Date 2025-09-01
Primary Completion 2027-02-01 (estimated)
Study Completion 2027-08-01 (estimated)
Updated on ClinicalTrials.gov 2026-04-14